勃起功能障碍
医学
不育
男性不育
人口
疾病
富血小板血浆
内科学
妇科
重症监护医学
血小板
怀孕
遗传学
环境卫生
生物
作者
Eleni Anastasiadis,Razna Ahmed,Abbas Khizar Khoja,Tet Yap
标识
DOI:10.3389/frph.2022.944765
摘要
Erectile dysfunction (ED) is one of the commonest disorders in adult males and affects 12-19% of men of reproductive age. Only few studies have evaluated the impact of ED on men and couples with infertility-these studies report higher rates of ED in this sub-group of men compared to the general population, with the prevalence of ED in men diagnosed with male infertility ranging from 6.7 to 61.6%. Nevertheless, ED is considered a rare cause of male infertility, accounting for about 0.4-5% of all causes of male infertility. ED remains a poorly treated condition globally and current therapies, like oral medication, offer only temporary symptomatic relief and do not influence disease progression-patients are potentially on lifelong treatment, with ED worsening over time. In contrast, regenerative medicine may potentially reverse or halt the progression of ED processes. In this article, we review the evidence for intracavernosal injections of platelet-rich plasma (PRP) in the treatment of ED.
科研通智能强力驱动
Strongly Powered by AbleSci AI